Health TrialsbyHealthPanel

Intravenous Lidocaine for Postoperative Fatigue After Laparoscopic TAPP Inguinal Hernia Repair

ConditionsPostoperative Fatigue SyndromeInguinal Hernia Unilateral
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHakan Emirkadı

About this trial

This prospective randomized controlled study aims to evaluate the effect of perioperative intravenous lidocaine infusion on postoperative fatigue syndrome in patients undergoing elective laparoscopic TAPP inguinal hernia repair. Participants will be randomly assigned to receive either intravenous lidocaine infusion or standard perioperative management without lidocaine. The primary objective is to assess postoperative fatigue and recovery quality. Secondary outcomes include postoperative pain, analgesic consumption, nausea-vomiting, mobilization time, and length of hospital stay.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Lidocaine

    Drug

    Perioperative intravenous lidocaine infusion will be administered according to the study protocol in patients undergoing elective laparoscopic TAPP inguinal hernia repair.

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Lidocaine GroupExperimental treatment 1 intervention
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Postoperative Fatigue Syndrome Score

Assessment of postoperative fatigue syndrome and recovery quality using postoperative follow-up evaluations conducted on postoperative days 1, 3 and 5 after elective laparoscopic TAPP inguinal hernia repair.

Time frame
Postoperative days 1, 3, 5

Secondary outcomes

1

Postoperative Pain Score

Assessment of postoperative pain scores during postoperative follow-up.

Time frame
Postoperative days 1, 3, and 5
2

Opioid Consumption

Total postoperative opioid consumption during the early postoperative period.

Time frame
Within postoperative 24 hours
3

Postoperative Nausea and Vomiting

Incidence of postoperative nausea and vomiting during the early postoperative period.

Time frame
Within postoperative 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hakan Emirkadı

Lead sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: